CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Bayraklı, Turkey

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

    Phase

    2

    Span

    111 weeks

    Sponsor

    Janssen Research & Development, LLC

    A Coruna

    Recruiting

  • A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

    Phase

    3

    Span

    175 weeks

    Sponsor

    Areteia Therapeutics

    A Coruna

    Recruiting

  • Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

    Phase

    2/3

    Span

    211 weeks

    Sponsor

    Kartos Therapeutics, Inc.

    A Coruna

    Recruiting

  • Study of M5049 in DM and PM Participants (NEPTUNIA)

    Phase

    2

    Span

    128 weeks

    Sponsor

    EMD Serono Research & Development Institute, Inc.

    A Coruna

    Recruiting

  • A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

    Phase

    3

    Span

    212 weeks

    Sponsor

    Seagen, a wholly owned subsidiary of Pfizer

    A Coruna

    Recruiting

  • Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

    This is an open-label, single arm, multicenter study designed to evaluate long-term safety and tolerability of inclisiran. In addition, the study will provide participants the opportunity to have continued access to treatment with inclisiran.

    Phase

    3

    Span

    264 weeks

    Sponsor

    Novartis Pharmaceuticals

    A Coruna

    Recruiting

  • A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

    Phase

    2/3

    Span

    225 weeks

    Sponsor

    argenx

    A Coruna

    Recruiting

  • Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

    Phase

    2

    Span

    209 weeks

    Sponsor

    Mirati Therapeutics Inc.

    A Coruna

    Recruiting

  • Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

    Phase

    2

    Span

    177 weeks

    Sponsor

    Kowa Research Institute, Inc.

    A Coruna

    Recruiting

  • Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

    Phase

    3

    Span

    454 weeks

    Sponsor

    Pfizer

    A Coruna

    Recruiting

1-10 of 32
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information